SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-16-125113
Filing Date
2016-06-02
Accepted
2016-06-02 16:15:26
Documents
3
Effectiveness Date
2016-06-02

Document Format Files

Seq Description Document Type Size
1 8-K a16-11395_28k.htm DEFA14A 25137
2 EX-99.1 a16-11395_2ex99d1.htm EX-99.1 9593
3 GRAPHIC g113952mmi001.jpg GRAPHIC 2768
  Complete submission text file 0001104659-16-125113.txt   39533
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33277 | Film No.: 161692632
SIC: 2834 Pharmaceutical Preparations